Pitavastatin Targets Mcl-1 to Overcome Paclitaxel-Resistant Triple-Negative Breast Cancer. (IMAGE)

Korea University College of Medicine

Pitavastatin Targets Mcl-1 to Overcome Paclitaxel-Resistant Triple-Negative Breast Cancer.

Caption

Pitavastatin binds and suppresses Mcl-1, targets cancer stem-like properties, triggers mitochondrial apoptosis, and restores paclitaxel sensitivity in triple-negative breast cancer models.

Credit

Professor Jae Hong Seo from Korea University

Usage Restrictions

Cannot be reused without permission

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.